Clinical Trial

Trial Protocol ID USOR 23235_EIK1001-005

Trial Description

A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer (EIK1001-005)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, MD

Disease Types

Sponsor

  • Eikon Therapeutics

ClinicalTrials.gov NCT ID

  • NCT06246110